Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03737279 · ClinicalTrials.gov registry record · NA

Daily Meditation Program in Women Admitted to the Antepartum Unit

A NA study of Pregnancy Related and Pregnancy, High Risk, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT03737279 is a NA study of Pregnancy Related and Pregnancy, High Risk that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 56 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03737279, a NA study of Pregnancy Related and Pregnancy, High Risk, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether a daily mindful meditation program for women admitted to the antepartum floor will decrease maternal state anxiety compared to routine care.

Interventions

  • BEHAVIORAL Meditation
  • BEHAVIORAL Routine Care

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2019-03-04
Est. Completion 2020-04-01
Phase NA

What the Registry Record Tells You About NCT03737279

The ClinicalTrials.gov registry entry for NCT03737279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (97% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Meditation is the first listed.

NCT03737279 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03737279 about?

NCT03737279 is a clinical study titled "Daily Meditation Program in Women Admitted to the Antepartum Unit". The purpose of this study is to assess whether a daily mindful meditation program for women admitted to the antepartum floor will decrease maternal state anxiety compared to routine care.

What is the current status of trial NCT03737279?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2019-03-04. Estimated completion is 2020-04-01.

What conditions does trial NCT03737279 study?

This clinical trial studies the following conditions: Pregnancy Related, Pregnancy, High Risk.

What interventions are being tested in trial NCT03737279?

The interventions under investigation include: Meditation (BEHAVIORAL), Routine Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT03737279?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03737279 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Related

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.